BPC-157 is a repair assist for joint pain, not a cure for arthritis
After treatment with CoCl, BPC157-treated HUVECs failed to form tube-like structures (Supplementary Figure S3B), which is consistent with our analysis that the redox state is a key determinant of BACH1s functional direction
Topical Forms: Research has been done on the use of topical forms in the healing of wounds, although further research is necessary
Important Research Limitations Several layers of uncertainty are hidden by the simple two-name marketing label
Regulatory Status: FDA, WADA, DEA BPC-157 occupies a defined position in the US regulatory landscape, and that position has changed in recent years
Low-T operators Physical injuries are just one of the challenges facing the special operations community